News | September 8, 2016

Webinar Aims To Break Down Barriers Around Single-Use Technology Implementation

Source: Parker Bioscience
Contact The Supplier
Graeme Proctor
Graeme Proctor, Product Manager – Single-use Technologies at Parker domnick hunter.

Bioprocessing manufacturers are being urged to overcome challenges to adopting single-use technology – with the help of an up-coming webinar hosted by bioprocessing specialist Parker domnick hunter.

The webinar, entitled Single-use Technologies, What is Next?, will aim to help companies explore solutions to the perceived ‘roadblocks’ surrounding the implementation of single-use systems in bioproduction processes, which can often lead to slower delivery at a higher cost of life-saving vaccines and other biopharmaceutical products.

Held on November 8, 2016, the webinar will address challenges concerning product compatibility, scalability, batch volumes and automation, as well as the integrity of single-use systems compared to stainless steel – for example in the case of transferring solvents, or handling high pressures and extreme temperatures.

Participants will be invited to share their concerns and will be given practical advice on how to implement single-use technology.

The webinar will be delivered by Graeme Proctor, Product Manager – Single-use Technologies at Parker domnick hunter, and will include a study on assembly integrity testing, a discussion on how automation can save time while increasing quality, and a presentation on a design for handling highly potent molecules which protects both the operator and the process.

Parker domnick hunter, which has lead operations in Birtley, UK and Oxnard, California, USA, is part of the Parker Hannifin Corporation, the world’s leading diversified manufacturer of motion and control technologies and systems. Parker domnick hunter designs, supplies and delivers whole systems for both upstream and downstream biopharmaceutical manufacturing, serving clients all over the world.

Parker domnick hunter specializes in the development of custom automated processes, incorporating sensor and control technologies, filtration products and single-use consumables. These single-use solutions help to standardize operations, identify, monitor and control bioprocess variation and ensure product quality and consistency when upscaling from development to manufacturing scale.

Commenting on his upcoming webinar, Graeme Proctor said: “It’s vital that biopharmaceutical manufacturers aren’t deterred from reaping the benefits of single-use technology – such as reduced cleaning requirements, decreased plant footprint, improved batch turnaround times, increased process flexibility and reduced risk of cross contamination – due to misconceptions or concerns regarding its implementation.

“This webinar will aim to address entrenched views on single-use technology and help manufacturers gain a more comprehensive understanding of its capabilities, which will support them in designing or re-designing their processes.”

Register for this free webinar at http://bit.ly/2bJng0a

About Parker domnick hunter
Parker domnick hunter provides integrated bioprocessing solutions that speed up development times, increase efficiency and safety, and enable reproducible quality. Incorporating SciLog®, Parker domnick hunter combines filtration, single-use fluid-handling systems and sensors into automated single-use solutions. Visit www.parker.com/dh-bioprocessing to learn how we can create your single-use solution.

About Parker Hannifin Corporation
With annual sales of $11 billion in fiscal year 2016, Parker Hannifin is the world's leading diversified manufacturer of motion and control technologies and systems, providing precision-engineered solutions for a wide variety of mobile, industrial and aerospace markets. The company has operations in 49 countries around the world. Parker has increased its annual dividends paid to shareholders for 60 consecutive fiscal years, among the top five longest-running dividend-increase records in the S&P 500 index. For more information, visit the company's website at www.parker.com, or its investor information website at www.phstock.com.

SOURCE: Parker Bioscience